Agnès Veyradier

5.8k total citations
108 papers, 3.3k citations indexed

About

Agnès Veyradier is a scholar working on Immunology, Hematology and Nephrology. According to data from OpenAlex, Agnès Veyradier has authored 108 papers receiving a total of 3.3k indexed citations (citations by other indexed papers that have themselves been cited), including 91 papers in Immunology, 62 papers in Hematology and 49 papers in Nephrology. Recurrent topics in Agnès Veyradier's work include Complement system in diseases (90 papers), Renal Diseases and Glomerulopathies (49 papers) and Platelet Disorders and Treatments (38 papers). Agnès Veyradier is often cited by papers focused on Complement system in diseases (90 papers), Renal Diseases and Glomerulopathies (49 papers) and Platelet Disorders and Treatments (38 papers). Agnès Veyradier collaborates with scholars based in France, Belgium and United States. Agnès Veyradier's co-authors include Paul Coppo, Dominique Meyer, Bernadette Obert, Bérangère S. Joly, Élie Azoulay, Lionel Galicier, Anne Houllier, Alain Stépanian, Virginie Siguret and Y. Benhamou and has published in prestigious journals such as Circulation, Blood and PLoS ONE.

In The Last Decade

Agnès Veyradier

102 papers receiving 3.2k citations

Peers

Countries citing papers authored by Agnès Veyradier

Since Specialization

Citations

This map shows the geographic impact of Agnès Veyradier's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Agnès Veyradier with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Agnès Veyradier more than expected).

Fields of papers citing papers by Agnès Veyradier

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Agnès Veyradier. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Agnès Veyradier. The network helps show where Agnès Veyradier may publish in the future.

Co-authorship network of co-authors of Agnès Veyradier

This figure shows the co-authorship network connecting the top 25 collaborators of Agnès Veyradier. A scholar is included among the top collaborators of Agnès Veyradier based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Agnès Veyradier. Agnès Veyradier is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

#	Work	Indexed citations
1	N-glycan shielded CUB domains of ADAMTS13 prevent binding of C-terminal antibodies in patients with immune-mediated TTP 2025 ·Blood Advances ·(unknown), (unknown), (unknown), (unknown), Paul Kaijen, Paul Coppo, Bérangère S. Joly, Agnès Veyradier, Karen Vanhoorelbeke, Jan Voorberg	0
2	Real-world evaluation of a novel automated method for measuring ADAMTS-13 activity using the Ceveron s100 analyzer 2025 ·Journal of Thrombosis and Haemostasis ·Bérangère S. Joly, (unknown), (unknown), (unknown), Virginie Siguret, (unknown), Agnès Veyradier	0
3	Diagnosis of thrombotic thrombocytopenic purpura: easy-to-use fiber optic surface plasmon resonance immunoassays for automated ADAMTS-13 antigen and conformation evaluation 2024 ·Journal of Thrombosis and Haemostasis ·(unknown), (unknown), (unknown), Edwige Tellier, Gilles Kaplanski, Bérangère S. Joly, Agnès Veyradier, Paul Coppo, Jeroen Lammertyn, Claudia Tersteeg, Simon F. De Meyer, Karen Vanhoorelbeke	3
4	Hemophagocytic lymphohistiocytosis is associated with deficiency and closed conformation of ADAMTS-13 2023 ·Research and Practice in Thrombosis and Haemostasis ·(unknown), Sandrine Valade, Éric Mariotte, Lionel Galicier, Élie Azoulay, Elien Roose, Karen Vanhoorelbeke, Agnès Veyradier, Bérangère S. Joly	1
5	Management and follow-up of pregnancy-onset thrombotic thrombocytopenic purpura: the French experience 2023 ·Blood Advances ·(unknown), Paul Coppo, Vassilis Tsatsaris, Pierre Boisseau, François Provôt, Yahsou Delmas, Pascale Poullin, Karen Vanhoorelbeke, Agnès Veyradier, Bérangère S. Joly	7
6	Magnesium sulphate in patients with thrombotic thrombocytopenic purpura (MAGMAT): a randomised, double-blind, superiority trial 2023 ·Intensive Care Medicine ·Lara Zafrani, Emmanuel Canet, Anouk Walter‐Petrich, (unknown), Agnès Veyradier, Stanislas Faguer, Naïke Bigé, Laure Calvet, Julien Mayaux, Steven Grangé, Cédric Rafat, (unknown), Kada Klouche, Pierre Perez, Frédéric Pène, Claire Pichereau, Baptiste Duceau, Éric Mariotte, Sylvie Chevret, Élie Azoulay	0
7	N-glycan–mediated shielding of ADAMTS13 prevents binding of pathogenic autoantibodies in immune-mediated TTP 2021 ·Blood ·(unknown), (unknown), Kadri Kangro, (unknown), Kanin Wichapong, (unknown), Paul Kaijen, Floris P. J. van Alphen, Maartje van den Biggelaar, Karen Vanhoorelbeke, Agnès Veyradier, Paul Coppo, Chris Reutelingsperger, Gerry A. F. Nicolaes, Andres Männik, Jan Voorberg	13
8	Amotosalen-inactivated fresh frozen plasma is comparable to solvent-detergent inactivated plasma to treat thrombotic thrombocytopenic purpura 2019 ·Transfusion and Apheresis Science ·Olivier Garraud, Sandrine Malot, Raoul Herbrecht, Mario Ojeda‐Uribe, Jin‐Sying Lin, Agnès Veyradier, Jean‐Marc Payrat, Kathy Liu, Laurence Corash, Paul Coppo	1
9	Dissecting the pathophysiology of immune thrombotic thrombocytopenic purpura: interplay between genes and environmental triggers 2018 ·Haematologica ·(unknown), (unknown), (unknown), (unknown), Karen Vanhoorelbeke, Agnès Veyradier, Jan Voorberg, Paul Coppo	31
10	Amplified endogenous plasmin activity resolves acute thrombotic thrombocytopenic purpura in mice 2017 ·Journal of Thrombosis and Haemostasis ·Claudia Tersteeg, Bérangère S. Joly, Ann Gils, Roger Lijnen, Hans Deckmyn, Paul Declerck, Barbara Plaimauer, Paul Coppo, Agnès Veyradier, Coen Maas, Simon F. De Meyer, Karen Vanhoorelbeke	14
11	Efficacy of Eculizumab in Gemcitabine-Induced Thrombotic Microangiopathy: Experience of the French Thrombotic Microangiopathies Reference Centre 2016 ·Blood ·Maximilien Grall, François Provôt, Jean‐Philippe Coindre, Claire Pouteil‐Noble, Dominique Guerrot, Y. Benhamou, Dominique Bordessoule, Agnès Veyradier, Paul Coppo, Steven Grangé	6
12	Epidemiology and pathophysiology of adulthood-onset thrombotic microangiopathy with severe ADAMTS13 deficiency (thrombotic thrombocytopenic purpura): a cross-sectional analysis of the French national registry for thrombotic microangiopathy 2016 ·The Lancet Haematology ·Éric Mariotte, Élie Azoulay, Lionel Galicier, Eric Rondeau, (unknown), Pierre Boisseau, Pascale Poullin, Emmanuel de Maistre, François Provôt, Yahsou Delmas, Pierre Perez, Y. Benhamou, Alain Stépanian, Paul Coppo, Agnès Veyradier	204
13	Acute renal failure is prevalent in patients with thrombotic thrombocytopenic purpura associated with low plasma ADAMTS13 activity 2014 ·Journal of Thrombosis and Haemostasis ·Lara Zafrani, Éric Mariotte, Michaël Darmon, Emmanuel Canet, Sybille Merceron, David Boutboul, Agnès Veyradier, Lionel Galicier, Élie Azoulay	50
14	ADAMTS, Thrombotic Thrombocytopenic Purpura and Pregnancy 2012 ·Agnès Veyradier	4
15	Thrombotic Microangiopathies: Towards a Pathophysiology-Based Classification 2009 ·Cardiovascular & Haematological Disorders - Drug Targets ·Paul Coppo, Agnès Veyradier	52
16	Time course of organ dysfunction in thrombotic microangiopathy patients receiving either plasma perfusion or plasma exchange* 2006 ·Critical Care Medicine ·Michaël Darmon, Élie Azoulay, Guillaume Thiéry, Magali Ciroldi, Lionel Galicier, Nathalie Parquet, Agnès Veyradier, Jean‐Roger Le Gall, Éric Oksenhendler, Benoı̂t Schlemmer	33
17	Physiopathologie du purpura thrombotique thrombocytopénique : actualités et perspectives 2002 ·Hématologie ·Agnès Veyradier, Anne Marfaing‐Koka, Jean‐Pierre Girma, Dominique Meyer	1
18	Protéolyse du facteur Willebrand et purpura thrombotique thrombocytopénique 2001 ·Hématologie ·Agnès Veyradier, Jean‐Pierre Girma, Dominique Meyer	1
19	Le PFA 100TM remplacera-t-il le temps de saignement ? 2000 ·Hématologie ·Marie‐Hélène Denninger, Édith Fressinaud, Marie‐Geneviève Huisse, Dominique Lasne, (unknown), Paquita Nurden, Agnès Veyradier, (unknown)	1
20	Case Report: Prothrombin 20210G/A Mutation in Two Patients with Mesenteric Ischemia 1999 ·Digestive Diseases and Sciences ·(unknown), Agnès Veyradier, Sylvie Naveau, M. Wolf, Sarah Montembault, Vincent Giraud, Eric Borotto, Christiani Jeyakumar Henry, Dominique Meyer, J C Chaput	11

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact